{
  "question_stem": {
    "en": "A 39-year-old woman comes to the office due to a nagging cough. Two weeks ago, the patient had a mild upper respiratory illness which resolved spontaneously after several days. Since then, she has had cough that is productive of minimal clear sputum. The patient has had no shortness of breath or chest pain. She took unexpired, leftover dextromethorphan for 2 days. The patient's only other medical condition is major depression, for which she takes sertraline. She does not use tobacco, alcohol, or illicit drugs. Vital signs and physical examination show no abnormalities. Use of dextromethorphan is most concerning for which of the following in this patient? {{exhibit_1}}",
    "zh": "一位39岁的女性因持续咳嗽前来就诊。两周前，患者患有轻微的上呼吸道疾病，数天后自愈。此后，她一直咳嗽，咳出少量清痰。患者没有出现呼吸困难或胸痛。她服用了未过期的、剩余的右美沙芬2天。患者唯一的其他疾病是重度抑郁症，她正在服用舍曲林。她不吸烟、不饮酒，也不吸食违禁药物。生命体征和体格检查未见异常。在该患者中，使用右美沙芬最令人担忧的是以下哪一项？{{exhibit_1}}"
  },
  "question": {
    "en": "Use of dextromethorphan is most concerning for which of the following in this patient?",
    "zh": "在该患者中，使用右美沙芬最令人担忧的是以下哪一项？"
  },
  "options": {
    "A": {
      "en": "Potential for recreational use",
      "zh": "娱乐性使用的可能性"
    },
    "B": {
      "en": "Drug-drug interaction",
      "zh": "药物相互作用"
    },
    "C": {
      "en": "Liver injury",
      "zh": "肝损伤"
    },
    "D": {
      "en": "Hypoventilation",
      "zh": "通气不足"
    },
    "E": {
      "en": "Rebound symptoms after discontinuation",
      "zh": "停药后的反跳症状"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "Dextromethorphan (DXM) is a popular cough suppressant (antitussive agent) that is readily available over the counter. Its primary mechanism of action is inhibition of the medullary cough center through sigma (σ) receptor activation. Although structurally very closely related to other opioid morphinans (eg, codeine, morphine), DXM has trivial mu (μ) and delta (δ) opioid receptor affinity. Therefore, classic opioid adverse effects (eg, constipation, respiratory depression, analgesia, sedation) are not seen at therapeutic doses. This favorable pharmacologic profile makes DXM a first-choice agent for cough suppression.\n\nHowever, DXM also increases serotonin activity in the CNS by decreasing the rate of presynaptic serotonin reuptake and directly stimulating serotonin receptors. For this reason, DXM abuse can cause SEROTONIN SYNDROME, manifesting as muscular hypertonia, spasticity (eg, clonus, hyperreflexia), autonomic instability (eg, hyperthermia, hypertension), and encephalopathy. This potentially fatal condition most often occurs in settings of overdose or accidental drug interaction with other serotonergic drugs (eg, selective serotonin reuptake inhibitors, triptans, monoamine oxidase inhibitors).\n\n(Choice A) Although DXM has the potential for abuse, addiction is less likely than with opioid cough suppressants (eg, codeine). Recreational drug use typically begins in peer settings, and adolescents and young adults are at greatest risk; this 39-year-old woman has no history of recreational drug use and is likely at low risk.\n\n(Choice C) DXM has no intrinsic hepatotoxicity. However, acute liver injury can occur in overdose scenarios involving combination dextromethorphan-acetaminophen preparations (eg, multi-symptom cold remedies).\n\n(Choice D) Although it has negligible μ receptor agonism at therapeutic doses, DXM at high doses may cause intoxication that can occasionally elicit enough μ receptor agonism to produce hypoventilation and stupor. These symptoms can be reversed with naloxone.\n\n(Choice E) Patients who use over-the-counter decongestants (eg, oxymetazoline or phenylephrine sprays, oral pseudoephedrine) for prolonged periods can develop rhinitis medicamentosa, characterized by rebound nasal congestion, rhinorrhea, and turbinate hypertrophy. However, rebound cough is not observed on DXM withdrawal.\n\nEducational objective:\nDextromethorphan (DXM) is a popular over-the-counter antitussive agent that acts on sigma receptors to suppress the medullary cough center. DXM also has an off-target action on serotonin transports and receptors in the CNS. Overdose or accidental interaction with other serotonergic medications (eg, selective serotonin reuptake inhibitors, antidepressants) can precipitate SEROTONIN SYNDROME.",
    "zh": "右美沙芬 (DXM) 是一种常用的止咳药（镇咳剂），可以非处方获得。它的主要作用机制是通过激活西格玛 (σ) 受体来抑制延髓咳嗽中枢。尽管在结构上与其他阿片类吗啡烷（如可待因、吗啡）非常相似，但 DXM 对 μ (mu) 和 δ (delta) 阿片受体的亲和力很低。因此，在治疗剂量下，不会出现经典的阿片类不良反应（如便秘、呼吸抑制、镇痛、镇静）。这种有利的药理学特征使 DXM 成为止咳的首选药物。\n\n然而，DXM 也会通过降低突触前血清素再摄取的速率并直接刺激血清素受体来增加中枢神经系统中的血清素活性。因此，DXM 滥用可引起血清素综合征，表现为肌肉张力过高、痉挛 (如阵挛、反射亢进)、自主神经功能不稳定（如高热、高血压）和脑病。这种潜在的致命情况最常发生在药物过量或与其他血清素能药物（如选择性血清素再摄取抑制剂、曲坦类药物、单胺氧化酶抑制剂）发生意外药物相互作用的情况下。\n\n(选项 A) 尽管 DXM 有被滥用的可能性，但成瘾的可能性低于阿片类止咳药（如可待因）。娱乐性药物使用通常始于同伴群体，青少年和年轻人面临的风险最大；这位39岁的女性没有娱乐性药物使用的病史，风险可能较低。\n\n(选项 C) DXM 没有内在的肝毒性。然而，在涉及复方右美沙芬-对乙酰氨基酚制剂（例如，多症状感冒药）的过量情况下，可能会发生急性肝损伤。\n\n(选项 D) 尽管在治疗剂量下，DXM 的 μ 受体激动作用可以忽略不计，但高剂量的 DXM 可能会引起中毒，偶尔会引起足够的 μ 受体激动作用，从而导致通气不足和木僵。这些症状可以通过纳洛酮逆转。\n\n(选项 E) 长期使用非处方减充血剂（例如，羟甲唑啉或苯肾上腺素喷雾剂、口服伪麻黄碱）的患者可能会发生药物性鼻炎，其特征是鼻塞反跳、鼻溢和鼻甲肥大。然而，在 DXM 戒断时，没有观察到咳嗽反跳。\n\n教育目标：\n右美沙芬 (DXM) 是一种常用的非处方镇咳剂，它作用于西格玛受体以抑制延髓咳嗽中枢。 DXM 对中枢神经系统中的血清素转运和受体也有脱靶作用。过量或与其他血清素能药物（如选择性血清素再摄取抑制剂、抗抑郁药）发生意外相互作用可诱发血清素综合征。"
  },
  "summary": {
    "en": "This question tests knowledge of potential drug interactions with dextromethorphan, specifically the risk of serotonin syndrome when combined with SSRIs. It requires understanding of dextromethorphan's mechanism of action and its potential to increase serotonin levels in the CNS. \n\nThe best approach is to consider the patient's current medications and identify potential interactions. Recognize that dextromethorphan can increase serotonin levels and that combining it with an SSRI like sertraline increases the risk of serotonin syndrome.",
    "zh": "本题考察了关于右美沙芬的潜在药物相互作用的知识，特别是与 SSRIs 联合使用时发生血清素综合征的风险。它要求了解右美沙芬的作用机制及其在中枢神经系统中增加血清素水平的潜力。\n\n最好的方法是考虑患者目前的用药情况并确定潜在的相互作用。认识到右美沙芬可以增加血清素水平，并且将其与舍曲林等 SSRI 联合使用会增加血清素综合征的风险。"
  },
  "tags": "Dextromethorphan; Serotonin syndrome; Drug-drug interaction; SSRI; Sertraline; Cough suppressant; Sigma receptor; Central nervous system",
  "category": "Chest",
  "question_id": "18669",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Chest 23\\18669",
  "extracted_at": "2025-11-05T11:41:46.057112",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:36:56.678744",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}